Codexis, Inc. (OQ:CDXS)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for CDXS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 14/19 Lalonde James Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,378  
May 15/19 May 14/19 Lalonde James Direct Ownership Common Stock S - Open market or private sale -2,378 $18.95
May 15/19 May 14/19 Lalonde James Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,378 $7.46
May 15/19 May 13/19 Lalonde James Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -17,621  
May 15/19 May 13/19 Lalonde James Direct Ownership Common Stock S - Open market or private sale -17,621 $18.61
May 15/19 May 13/19 Lalonde James Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 17,621 $7.46
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 40,000  
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Common Stock S - Open market or private sale -40,000 $20.91
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 40,000 $4.10
Mar 22/19 Mar 20/19 Sangster Gordon Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 40,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CDXS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 14/19 Lalonde James Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,378  
May 15/19 May 13/19 Lalonde James Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -17,621  
May 15/19 May 14/19 Lalonde James Direct Ownership Common Stock S - Open market or private sale -2,378 $18.95
May 15/19 May 14/19 Lalonde James Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,378 $7.46
May 15/19 May 13/19 Lalonde James Direct Ownership Common Stock S - Open market or private sale -17,621 $18.61
May 15/19 May 13/19 Lalonde James Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 17,621 $7.46
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 40,000  
Mar 22/19 Mar 20/19 Sangster Gordon Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 40,000  
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Common Stock S - Open market or private sale -40,000 $20.91
Mar 22/19 Mar 21/19 Sangster Gordon Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 40,000 $4.10
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $CDXS

StockTwits